Evoco has acquired leading med tech company, as part of Austrian portfolio transaction

Evoco is pleased to announce that Evoco TSE III has acquired 100 % of the Agency for Medical Innovations (A.M.I., www.ami.at) from aws Mittelstandsfonds and other shareholders.

A.M.I., headquartered in Feldkirch, is an Austrian manufacturer of high-quality medical technology and products. The Company was founded in 1998 and employs over 125 people in Austria and several international sales subsidiaries. A.M.I. seeks to improve the quality of patient care by developing innovative products and treatment methods for surgical application. The company’s product portfolio is centred around the core disciplines of urology, urogynaecology and coloproctology, significantly contributing to patients’ quality of life, through minimally invasive medical procedures.

Evoco will support A.M.I.’s plans for next level growth and closely collaborate with the existing management team to capitalise on untapped value creation potential. The Company will be able to leverage the Evoco toolkit, particularly in the areas of governance and distribution expansion.

Michel Galeazzi, Partner & Co-Founder of Evoco, commented, “We are excited to collaborate with A.M.I. and take an active role in the development and future success of the Company. We are impressed with A.M.I.’s outstanding reputation and high-quality products in specialised markets, expected to benefit from long term demographic trends.”

Lorenzo Sormani, Director at Evoco, added, “This transaction is an excellent demonstration of Evoco’s strategy of investing in resilient companies, operating in attractive segments, with the potential to deliver on untapped growth and value.”

Nina Dohrau and Christoph Haimberger, Management Board of aws Mittelstandsfonds, commented, “We are pleased the transaction has been completed successfully and believe that Evoco represents a strong equity partner for the portfolio companies. Evoco not only supports further growth of the companies, it also elevates our national investments to a European level, strengthening Austrian’s position as an attractive business region.”

As part of the transaction Evoco will also acquire stakes in two additional companies, Document.One (www.document.one) and Communi5 (www.communi5.com). Document.One, headquartered in Vienna, is active in Enterprise Content Management (ECM). Communi5, also headquartered in Vienna, is a software manufacturer of communications solutions for service providers. We are pleased to partner with Document.One and Communi5 and look forward to working closely on their continued growth.

Schindler Attorneys, Medows and Grant Thornton advised the Evoco team on the transaction.
On the sell side, WMWP and Clairfield advised aws Mittelstandsfonds on the transaction.

_____________________

About Evoco
Evoco AG is a lower mid-market manager based in Zurich, investing in growth and buyout investments in Western Europe, with a focus on the DACH region. Since 2012, Evoco has invested in 25 companies. This is the second portfolio investment for Evoco TSE III, which held its final close in December 2021.

About aws Mittelstandsfonds
aws Mittelstandsfonds is a growth equity fund based in Vienna, offering equity and mezzanine capital investments for Austrian small and medium sized enterprises. So far, together with co-investors, around EUR 160 million have been invested in more than 20 portfolio companies, including several successful exits. aws Mittelstandsfonds is a 100% subsidiary of Austria Wirtschaftsservice.